Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer immunotherapy
cancer immunotherapy
It's the Little Things That Matter for Peregrine Pharmaceuticals
Motley Fool
Fri, 12/4/15 - 08:11 pm
Peregrine Pharmaceuticals
bavituximab
cancer immunotherapy
Merck KGaA, Pfizer widen development of cancer immunology drug
Yahoo/Reuters
Wed, 11/4/15 - 02:05 pm
Merck KGaA
Pfizer
cancer immunotherapy
avelumab
GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment
Yahoo
Tue, 11/3/15 - 02:17 pm
GSK
Merck
GSK3174998
Keytruda
cancer immunotherapy
Successful trials not all Juno needs to get cancer treatment to market
Bizjournals.com
Fri, 10/30/15 - 04:01 pm
Juno Therapeutics
cancer immunotherapy
Novartis
Kite Pharma
Going After Customized Lung Cancer Vaccines, Gritstone Grabs $102M
Forbes
Tue, 10/20/15 - 06:05 pm
vaccines
Gritstone Oncology
lung cancer
cancer immunotherapy
Bristol-Myers, Five Prime enter licensing deal of up to $1.74 bln
Yahoo/Reuters
Thu, 10/15/15 - 08:44 am
Bristol-Myers Squibb
Five Prime
FPA008
cancer immunotherapy
An inside look at Lilly's NYC expansion & focus on cancer immunotherapy
BioPharma Dive
Fri, 10/9/15 - 10:37 am
Eli Lilly
cancer immunotherapy
NYC
Cancer Immunotherapy Developer Galena Biopharma Can't Win for Trying
Motley Fool
Tue, 10/6/15 - 09:54 am
cancer immunotherapy
Galena Biopharma
Zuplenz
Abstral
Which Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market?
Motley Fool
Wed, 09/30/15 - 07:59 pm
cancer immunotherapy
Juno Therapeutics
Kite Pharma
Celgene
Bluebird Bio
AstraZeneca
Pfizer
Bristol-Myers Squibb
How Bioinformatics Could Find The Next Breakthrough Cancer Drug
Forbes
Wed, 08/12/15 - 10:51 am
bioinformatics
cancer
cancer immunotherapy
AstraZeneca bags another cancer drug deal, this time with Inovio
Yahoo/Reuters
Mon, 08/10/15 - 07:59 am
AstraZeneca
Inovio
INO-3112
HPV
cancer immunotherapy
Merck signs a $605M deal to bulk up in cancer immunotherapy
Fierce Biotech
Wed, 07/29/15 - 10:17 am
Merck
cancer immunotherapy
cCAM Biotherapeutics
CM-24
Keytruda
Sanofi links with Regeneron in $2.2 bln cancer drug push
Yahoo/Reuters
Tue, 07/28/15 - 10:03 am
Sanofi
Regeneron
cancer immunotherapy
R&D
Celgene Boldly Goes Where Few Have Gone Before
Motley Fool
Mon, 07/13/15 - 11:07 am
Celgene
Juno Therapeutics
cancer immunotherapy
How does the Keytruda-Opdivo marketing battle stack up?
Fierce Pharma Marketing
Mon, 07/13/15 - 11:05 am
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
cancer immunotherapy
Payers think they can squeeze prices on cancer immunotherapies? Not so fast, analyst says
Fierce Biotech
Fri, 07/10/15 - 12:25 pm
cancer immunotherapy
payer negotiation
A cancer cure that excites investors: A look at Seattle's immunotherapy deals of 2015
Bizjournals.com
Wed, 06/10/15 - 09:48 am
cancer immunotherapy
Juno Therapeutics
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
Forbes
Wed, 06/3/15 - 11:04 am
ASCO
cancer immunotherapy
glioblastoma multiforme
Merck
Genentech
Celldex Therapeutics
Merck KGaA sees immunotherapy drug holding its own in cancer race
Yahoo/Reuters
Tue, 06/2/15 - 09:06 am
Merck KGaA
avelumab
Pfizer
ASCO
cancer immunotherapy
Roche immunotherapy improves lung cancer survival
Yahoo/Reuters
Thu, 05/14/15 - 09:51 am
Roche
lung cancer
cancer immunotherapy
MPDL3280A
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »